The Progress of Induced Pluripotent Stem Cells as Models of Parkinson's Disease
In recent years, induced pluripotent stem cells (iPSCs) were widely used for investigating the mechanisms of Parkinson's disease (PD). Somatic cells from patients with SNCA (α-synuclein), LRRK2 (leucine-rich repeat kinase 2), PINK1 (PTEN induced putative kinase 1), Parkin mutations, and at-risk...
Saved in:
Main Authors: | Ji-feng Kang (Author), Bei-sha Tang (Author), Ji-feng Guo (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modeling Parkinson's Disease Using Induced Pluripotent Stem Cells
by: Xinchao Hu, et al.
Published: (2020) -
Cell therapy for Parkinson's disease with induced pluripotent stem cells
by: Asuka Morizane
Published: (2023) -
Disease-specific pluripotent stem cells
by: Hoon-Chul Kang
Published: (2010) -
Induced Pluripotent Stem Cells: Development in the Ophthalmologic Field
by: Nan Wu, et al.
Published: (2016) -
Modeling Neuropsychiatric and Neurodegenerative Diseases With Induced Pluripotent Stem Cells
by: Elizabeth A. LaMarca, et al.
Published: (2018)